AI is about to change healthcare. These 43 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
To own ASA Gold and Precious Metals today, you have to believe in two things at once: the underlying appeal of its precious metals exposure and the value that might be unlocked through the ongoing governance shake‑up. Recent results, including half‑year net income of US$287.35 million driven by large one‑off gains, show how headline numbers can be distorted, which makes the evolving structure even more important. Saba’s latest proposal to bring in a private credit manager as subadviser for a restructured BDC suggests a possible pivot away from a pure gold‑equity identity, and that could become a key short term catalyst if shareholders back the change. At the same time, rapid board turnover, a very new management team and public disputes with former adviser Merk Investments keep governance risk front and center.
However, investors should be aware of how the governance battle could reshape ASA’s core mandate. ASA Gold and Precious Metals' shares have been on the rise but are still potentially undervalued by 38%. Find out what it's worth.Explore 2 other fair value estimates on ASA Gold and Precious Metals - why the stock might be worth over 3x more than the current price!
Disagree with this assessment? Extraordinary investment returns rarely come from following the herd, so go with your instincts.
Markets shift fast. These stocks won't stay hidden for long. Get the list while it matters:
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com